# EUR-Lex - 52005XC1230(02) - EN

Important legal notice

*|*

# 52005XC1230(02)

**Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 November 2005 to 19 November 2005 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) **

*
Official Journal C 334 , 30/12/2005 P. 0035 - 0037 *

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 November 2005 to 19 November 2005

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC [1] or Article 38 of Directive 2001/82/EC [2])

(2005/C 334/07)

Issuing, maintenance or modification of a national marketing authorisation

Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |

7.11.2005 | Coversyl | See Annex | See Annex | 24.11.2005 |

[1] OJ L 311, 28.11.2001, p. 67.

[2] OJ L 311, 28.11.2001, p. 1.

--------------------------------------------------

ANNEX

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

Member State | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical form | Route of administration |

Austria | Servier Austria GmbH | COVERSUM | 2 mg | Tablets | Oral use |

Austria | Servier Austria GmbH | COVERSUM | 4 mg | Tablets | Oral use |

Belgium | Servier Benelux S.A. | COVERSYL | 2 mg | Tablets | Oral use |

Belgium | Servier Benelux S.A. | COVERSYL | 4 mg | Tablets | Oral use |

Denmark | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Denmark | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Finland | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Finland | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

France | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

France | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Germany | Les Laboratoires Servier | COVERSUM COR | 2 mg | Tablets | Oral use |

Germany | Les Laboratoires Servier | COVERSUM | 4 mg | Tablets | Oral use |

Greece | Servier Hellas Pharmaceuticals S.A. | COVERSYL | 2 mg | Tablets | Oral use |

Greece | Servier Hellas Pharmaceuticals S.A. | COVERSYL | 4 mg | Tablets | Oral use |

Iceland | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Iceland | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Ireland | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Ireland | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Italy | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Luxembourg | Servier Benelux S.A. | COVERSYL | 2 mg | Tablets | Oral use |

Luxembourg | Servier Benelux S.A. | COVERSYL | 4 mg | Tablets | Oral use |

Netherlands | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Netherlands | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Norway | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Norway | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Portugal | Servier Portugal — Especialidades Farmacêuticas | COVERSYL | 2 mg | Tablets | Oral use |

Portugal | Servier Portugal — Especialidades Farmacêuticas | COVERSYL | 4 mg | Tablets | Oral use |

Spain | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

Sweden | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

Sweden | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

United Kingdom | Les Laboratoires Servier | COVERSYL | 2 mg | Tablets | Oral use |

United Kingdom | Les Laboratoires Servier | COVERSYL | 4 mg | Tablets | Oral use |

--------------------------------------------------